Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Acquisitions & Divestments (2019 - 2020)

Catheter Precision (VTAK) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with $5.0 million as the latest value for Q2 2020.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $5.0 million in Q2 2020 year-over-year; TTM through Dec 2020 was $16.0 million, a N/A change, with the full-year FY2020 number at $16.0 million, down 22.69% from a year prior.
  • Change in Acquisitions & Divestments was $5.0 million for Q2 2020 at Catheter Precision, down from $11.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $11.0 million in Q1 2020 to a low of $5.0 million in Q2 2020.